Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

MLA

Wills, Anne-Marie, et al. “Hypercaloric Enteral Nutrition in Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Phase 2 Trial.” Lancet (London, England), vol. 383, no. 9934, June 2014, pp. 2065–72. EBSCOhost, https://doi.org/10.1016/S0140-6736(14)60222-1.

APA

Wills, A.-M., Hubbard, J., Macklin, E. A., Glass, J., Tandan, R., Simpson, E. P., Brooks, B., Gelinas, D., Mitsumoto, H., Mozaffar, T., Hanes, G. P., Ladha, S. S., Heiman-Patterson, T., Katz, J., Lou, J.-S., Mahoney, K., Grasso, D., Lawson, R., Yu, H., & Cudkowicz, M. (2014). Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet (London, England), 383(9934), 2065–2072. https://doi.org/10.1016/S0140-6736(14)60222-1

Chicago

Wills, Anne-Marie, Jane Hubbard, Eric A Macklin, Jonathan Glass, Rup Tandan, Ericka P Simpson, Benjamin Brooks, et al. 2014. “Hypercaloric Enteral Nutrition in Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Phase 2 Trial.” Lancet (London, England) 383 (9934): 2065–72. doi:10.1016/S0140-6736(14)60222-1.